Spherophakia associated with molybdenum cofactor deficiency

被引:0
|
作者
Parini, O
Briscioli, V
Caruso, U
Dorche, C
Fortuna, R
Minniti, G
Selicorni, A
Vismara, E
Mancini, G
机构
[1] OSPED IST CLIN PERFEZIONAMENTO, IST PEDIAT, MILAN, ITALY
[2] OSPED IST CLIN PERFEZIONAMENTO, LAB CITOGENET, MILAN, ITALY
[3] IST GIANNINA GASLINI, LAB CLIN PEDIAT 1, I-16148 GENOA, ITALY
[4] HOP DEBROUSSE, SERV BIOCHIM, LYON, FRANCE
[5] OSPED IST CLIN PERFEZIONAMENTO, DIV OCULIST, MILAN, ITALY
[6] ERASMUS UNIV ROTTERDAM, DEPT CELL BIOL & CLIN GENET, ROTTERDAM, NETHERLANDS
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 1997年 / 73卷 / 03期
关键词
spherophakia; molybdenum cofactor deficiency; sulfite oxidase deficiency; lens dislocation;
D O I
10.1002/(SICI)1096-8628(19971219)73:3<272::AID-AJMG8>3.0.CO;2-U
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Molybdenum cofactor deficiency is an autosomal recessive disorder characterized by lack of activity of the enzymes sulfite oxidase, aldehyde oxidase, and xanthine dehydrogenase or oxidase. The clinical manifestations are indistinguishable from those of isolated sulfite oxidase deficiency: craniofacial alterations, intractable neonatal convulsions, very severe mental retardation, lens dislocation, and death in the first decade of life. Lens dislocation is found in nearly all patients after neonatal age, In the present case it developed late (at the age of 8 years) and was preceded by bilateral spherophakia. We hypothesize that an abnormal relaxation, of the zonular fibers is the cause of spherophakia in this disease; this causes lens dislocation eventually, after days, months, or years. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:272 / 275
页数:4
相关论文
共 50 条
  • [41] Molybdenum cofactor and human disease
    Schwarz, Guenter
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2016, 31 : 179 - 187
  • [42] Pyridoxine-dependent Epilepsy With Elevated Urinary α-Amino Adipic Semialdehyde in Molybdenum Cofactor Deficiency
    Struys, Eduard Alexander
    Nota, Benjamin
    Bakkali, Abdellatif
    Al Shahwan, Saad
    Salomons, Gajja Sophi
    Tabarki, Brahim
    PEDIATRICS, 2012, 130 (06) : E1716 - E1719
  • [43] New Neuroimaging Findings in Patients with Molybdenum Cofactor Deficiency Type A: A Case Report and Literature Review
    Liu, Hui
    Yu, Xiaohe
    He, Singting
    Li, Shuquan
    CURRENT MEDICAL IMAGING, 2024, 20
  • [44] A mild case of molybdenum cofactor deficiency defines an alternative route of MOCS1 protein maturation
    Mayr, Simon Julius
    Sass, Joern Oliver
    Vry, Julia
    Kirschner, Janbernd
    Mader, Irina
    Hoevener, Jan-Bernd
    Reiss, Jochen
    Santamaria-Araujo, Jose Angel
    Schwarz, Guenter
    Gruenert, Sarah Catharina
    JOURNAL OF INHERITED METABOLIC DISEASE, 2018, 41 (02) : 187 - 196
  • [45] S-sulfocysteine/NMDA receptor-dependent signaling underlies neurodegeneration in molybdenum cofactor deficiency
    Kumar, Avadh
    Dejanovic, Borislav
    Hetsch, Florian
    Semtner, Marcus
    Fusca, Debora
    Arjune, Sita
    Santamaria-Araujo, Jose Angel
    Winkelmann, Aline
    Ayton, Scott
    Bush, Ashley I.
    Kloppenburg, Peter
    Meier, Jochen C.
    Schwarz, Guenter
    Belaidi, Abdel Ali
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (12): : 4365 - 4378
  • [46] Case Report: Compound Heterozygous Variants in MOCS3 Identified in a Chinese Infant With Molybdenum Cofactor Deficiency
    Tian, Qi
    Cao, Yang
    Shu, Li
    Chen, Yongjun
    Peng, Ying
    Wang, Yaqin
    Chen, Yuanyuan
    Wang, Hua
    Mao, Xiao
    FRONTIERS IN GENETICS, 2021, 12
  • [47] Genotype-Phenotype Dissociation in Two Taiwanese Children with Molybdenum Cofactor Deficiency Caused by MOCS2 Mutation
    Lee, Hsiu-Fen
    Hsu, Chia-Chi
    Chi, Ching-Shiang
    Tsai, Chi-Ren
    NEUROPEDIATRICS, 2022, 53 (03) : 200 - 203
  • [48] Molybdenum cofactor deficiency causes translucent integument, male-biased lethality, and flaccid paralysis in the silkworm Bombyx mori
    Fujii, Tsuguru
    Yamamoto, Kimiko
    Banno, Yutaka
    INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2016, 73 : 20 - 26
  • [49] Pharmacodynamic profiling in three patients with molybdenum cofactor deficiency type A reveals prolonged biological effects after withdrawal of cyclic pyranopterin monophosphate
    Schwahn, B. C.
    Barvikova, K.
    Wu, H. T.
    Horman, A.
    Emmett, E.
    Kozich, V.
    MOLECULAR GENETICS AND METABOLISM, 2024, 143 (1-2)
  • [50] Molybdenum cofactor and isolated sulphite oxidase deficiencies: Clinical and molecular spectrum among Egyptian patients
    Zaki, Maha S.
    Selim, Laila
    EL-Bassyouni, Hala T.
    Issa, Mahmoud Y.
    Mahmoud, Iman
    Ismail, Samira
    Girgis, Mariane
    Sadek, Abdelrahim A.
    Gleeson, Joseph G.
    Hamid, Mohamed S. Abdel
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2016, 20 (05) : 714 - 722